The briefing
A randomized clinical trial published in Clinical Infectious Diseases found that screening and treating pregnant patients twice for three common STIs was associated with a 23% lower risk of preterm birth versus standard care. The research was led by teams at the University of Pennsylvania and the University of Southern California.
Original headline
Two rounds of prenatal STI screening lower preterm birth risk